Space and astronomy
Experimental Drug Reverses Signs of Liver Aging in Rats, Halving Alzheimer’s-Linked Protein
A two-week treatment with cinaciguat restored key functions in aging liver cells in rats, lowering blood amyloid beta by about half and bringing LDL cholesterol to levels seen in younger animals. Researchers say the findings are preliminary and have not been shown to prevent Alzheimer’s disease in people.